Clinical trial
BDNF Gene Polymorphism and Antidepressants Treatment
NCT00308893 · University Hospital, Tours, Other · Completed
Key facts
| NCT number | NCT00308893 |
|---|---|
| Title | BDNF Gene Polymorphism and Antidepressants Treatment |
| Official title | Brain Derived Neurotrophic Factor (BDNF) Gene Polymorphism and Response to Antidepressants Treatment in Major Depression |
| Lead sponsor | University Hospital, Tours, Other |
| Collaborators | H. Lundbeck A/S Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Genetic |
| Interventions | Genetic analysis |
| Enrollment | 188 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Mar 30, 2006 |
| Last update posted | Dec 23, 2025 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: